Target intelligence / Profile preview

Dynein axonemal heavy chain 11 (DNAH11)

Target
DNAH11
Molecular classification
Motor protein, Microtubule-dependent ATPase, Axonemal dynein heavy chain family
01

Overview

Dynein axonemal heavy chain 11 is a large motor protein forming a critical component of the ciliary outer dynein arm, functioning as an ATPase that generates the force required for beating of motile cilia and flagella by moving toward the minus end of microtubules[1][5][6]. DNAH11 localizes to the *proximal region* of the respiratory cilia axoneme, and its activity is vital for proper ciliary bending and waveform generation. The protein is essential for embryonic left-right axis determination, effective mucociliary clearance in the respiratory tract, and normal sperm motility[2][4][6][7]. Mutations in the DNAH11 gene lead to *structure-function defects* in cilia, causing primary ciliary dyskinesia (often with normal ultrastructure but abnormal beating), situs inversus, infertility in males, and sometimes congenital heart defects; pathogenic variants can serve as diagnostic genetic markers but have not been targeted pharmacologically[3][4][6].

Other names
Dnahc11DPL11CILD7DNAHC11DNAHBLDNHBLLeft-right dynein (in mice, *lrd*)Axonemal beta dynein heavy chain 11Ciliary dynein heavy chain 11Dynein, ciliary, heavy chain 11Dynein, heavy chain beta-likeDynein, axonemal, heavy polypeptide 11Other cited abbreviations above
02

Mechanism of action

Not applicable. No known drugs directly target DNAH11; mechanisms described are for loss-of-function mutations causing impaired force generation in cilia[2][4].

03

Biological functions

Ciliary motility (respiratory tract, sperm, embryogenesis)Establishment of left-right body asymmetry during developmentSperm motility
04

Disease associations

Primary ciliary dyskinesia (PCD)Kartagener syndromeSitus inversus totalisCongenital heart disease (CHD)
05

Safety considerations

Not applicable to drugs; however, DNAH11 mutations cause severe congenital conditions (respiratory dysfunction, laterality defects), potentially affecting disease management and genetic counseling[3][4][6][7].
06

Biomarkers

Pathogenic DNAH11 variants are genetic biomarkers to diagnose inherited forms of primary ciliary dyskinesia, Kartagener syndrome, and related situs abnormalities[3][4][6][7].

Beyond the preview

Go deeper on Dynein axonemal heavy chain 11 (DNAH11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynein axonemal heavy chain 11 (DNAH11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call